Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bupropion for Depression in ESRD Patients on Hemodialysis

NCT02238977 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT02238977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bupropion for Depression in ESRD Patients on Hemodialysis
Lead sponsor
University of Arkansas
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2016
Completion date
March 1, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, major depression